Single Family Office

Updated:

Boze Family Office

Boze Family Office manages over RMB 4 billion from Beijing with focus on global allocation and family succession.

Boze Family Office logo

Boze Family Office

Yu Hongru established Boze Family Office in 2009 with registered capital of RMB 300 million. The office was created to manage and transfer the wealth generated by his pharmaceutical company, Jinzhou Aohong Pharmaceutical. It remains a single-family office headquartered in Beijing with foreign subsidiaries in Hong Kong. The firm allocates across equity investments, private equity, private credit, hedge funds, real estate and fund-of-funds vehicles. It targets early-stage and venture capital opportunities with emphasis on pharmaceuticals, consumer goods and TMT sectors. Geographic reach covers Asia, Europe and North America. Investment decisions draw on an internal research team of over 20 professionals whose average experience exceeds 15 years. Boze Family Office maintains a 20-person investment research system. It operates Intuition Capital, founded in 2021, as a separate second-generation venture fund. No operational events from the last 24 months appear in public records.

General information

Firm type

Single Family Office

Year founded

2009

AUM

571 (Altss estimate)

Location

Region

Asia

Country

China

City

Beijing

Corporate office

Unit 516, North Tower, Beijing Kerry Centre, Beijing, China

Additional offices

Hong Kong

Principals

Yu Hongru

Founder

Altss tracks 1 additional named team member for this firm — including direct investment leads, IR, and operating principals not listed on the public website.

Book a demo

Sector focus

Healthcare ServicesIndustrial TechMedia & EntertainmentFinTechSports & WellnessRobotics & AutomationDigital HealthMobility & TransportationAI/MLBiotechEnterprise SoftwareSemiconductors

Frequently asked questions

Who runs investment decisions at Boze Family Office?

Yu Hongru serves as founder and leads the firm. An internal team of over 20 investment professionals with pharmaceutical and financial backgrounds executes day-to-day allocation.

How does Boze Family Office source proprietary deal flow?

The firm combines direct relationships in the pharmaceutical sector with access to sub-funds and co-investment opportunities across Asia, Europe and North America.

Is Boze Family Office structured as a single family office or does it operate more like a venture firm?

It remains a single-family office. It also runs Intuition Capital as an independent second-generation venture vehicle started in 2021.

Does Boze Family Office participate in fund commitments or only direct deals?

It commits to funds and executes direct equity investments, alternative investments and customized mandates.

What investment stages does Boze Family Office typically target?

Early stage and venture capital form the core focus alongside allocations to primary and secondary markets.

Where does the underlying wealth come from?

The founding family accumulated its capital through Jinzhou Aohong Pharmaceutical, a bio-pharmaceutical company founded by Yu Hongru.

How is Boze Family Office related to Intuition Capital?

Intuition Capital was founded in 2021 with start-up capital from the Boze family and operates independently under a value-investment mandate.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on family offices?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Beijing Single Family Office profiles